Edition:
United Kingdom

BiondVax Pharmaceuticals Ltd (BVXV.OQ)

BVXV.OQ on NASDAQ Stock Exchange Capital Market

7.00USD
25 Apr 2019
Change (% chg)

-- (--)
Prev Close
$7.00
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
2,266
52-wk High
$7.26
52-wk Low
$3.87

Revenue & Earnings Per Share

Consensus Estimates Analysis

No consensus analysis data available.

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.30 32.55
P/E High - Last 5 Yrs. -- 147.69 48.10
P/E Low - Last 5 Yrs. -- 47.94 23.42
Beta -- 1.08 0.87
Price to Sales (TTM) -- 49.51 8.39
Price to Book (MRQ) -- 10.13 5.27
Price to Tangible Book (MRQ) -- 13.74 6.74
Price to Cash Flow (TTM) -- 56.16 24.12
% Owned Institutions -- 3.71 1.65

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.35
Dividend Yield - 5 Year Avg -- 0.09 1.37
Dividend 5 Year Growth Rate -- 0.78 4.70
Payout Ratio(TTM) -- 7.02 39.61

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 206.06 13.46
Sales (TTM) vs TTM 1 Yr. Ago -- 49.00 8.04
Sales - 5 Yr. Growth Rate -- 22.77 10.84
EPS (MRQ) vs Qtr. 1 Yr. Ago -- 75.31 47.73
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 11.97 10.46
Capital Spending - 5 Yr. Growth Rate -- 9.11 14.68

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.24 2.18
Current Ratio (MRQ) -- 3.57 2.98
LT Debt to Equity (MRQ) -- 18.63 11.33
Total Debt to Equity (MRQ) -- 31.30 16.01
Interest Coverage (TTM) -- -43.11 28.44

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.27 52.41
Gross Margin - 5 Yr. Avg. -- 60.50 50.39
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -110.68 12.41
Operating Margin (TTM) -- -185.03 5.73
Operating Margin - 5 Yr. Avg. -- -127.16 8.01
Pre-Tax Margin (TTM) -- -175.73 4.75
Pre-Tax Margin - 5 Yr. Avg. -- -132.95 8.28
Net Profit Margin (TTM) -- -182.45 1.48
Net Profit Margin - 5 Yr. Avg. -- -137.35 4.69
Effective Tax Rate (TTM) -- 22.47 22.13
Effective Tax Rate - 5 Yr. Avg. -- 15.50 22.58

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 7,653,404 820,403,999
Net Income/Employee (TTM) -- 513,580 92,865,213
Receivable Turnover (TTM) -- 6.28 5.82
Inventory Turnover (TTM) -- 1.89 3.41
Asset Turnover (TTM) -- 0.32 0.90

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 6.38 10.60
Return on Assets - 5 Yr. Avg. -- 5.47 11.78
Return on Investment (TTM) -- 8.91 13.83
Return on Investment - 5 Yr. Avg. -- 6.79 15.32
Return on Equity (TTM) -- 10.06 15.25
Return on Equity - 5 Yr. Avg. -- 8.32 16.41

Performance for BiondVax Pharmaceuticals Ltd

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.